AJ Vaccines Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- AJ Vaccines's estimated annual revenue is currently $119.2M per year.
- AJ Vaccines's estimated revenue per employee is $201,000
- AJ Vaccines has 593 Employees.
- AJ Vaccines grew their employee count by 16% last year.
- AJ Vaccines currently has 1 job openings.
What Is AJ Vaccines?
AJ Vaccines produces and sells vaccines from the production site in central Copenhagen. The production is taken over from SSI, and was until January 2017 owned by the Danish Government. AJ Vaccines has thus taken over a company with a very proud history of vaccine manufacturing The vaccine manufacturing at the site started as early as 1902 when a serum against Diphteria was produced. Today AJ Vaccines still produces vaccine against Diphteria, besides vaccines that protects against Whooping Cough, Tetanus, Tuberculosis and Polio. AJ Vaccines plans to increase the production of vaccinedoses in the years to come. At the moment there is a need for more polio vaccine: If more children are vaccinated it will be possible to exterminate polio here on earth within the next 15 years. Therefore an increased poliovaccine production is an important part of the ramp up plan, which however implies an overall increase of the vaccineproduction at the site. AJ Vaccines currently employs app. 680 employees, but the number of employees will increase in the next couple of years in order to fullfill the ambitious growth planskeywords:N/A